Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: A proof of principle

Glioblastoma (GBM) is the most aggressive primary brain tumor in adults, which remains difficult to cure. The very high recurrence rate has been partly attributed to the presence of GBM stem-like cells (GSCs) within the tumors, which have been associated with elevated chemokine receptor 4 (CXCR4) ex...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Judit Sanchez Gil, Maxime Dubois, Virginie Neirinckx, Arnaud Lombard, Natacha Coppieters, Paolo D’Arrigo, Damla Isci, Therese Aldenhoff, Benoit Brouwers, Cédric Lassence, Bernard Rogister, Marielle Lebrun, Catherine Sadzot-Delvaux
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2022-09-01
Edice:	Molecular Therapy: Oncolytics
Témata:	virotherapy HSV glioblastoma glioblastoma stem-like cells GBM GSC
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S237277052200078X
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!